University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 3 of 14
Gabapentin to Reduce Opioid Use Postoperatively (GROUP) in Children
NCT04724252
Prospective Evaluation of Topical Almond Oil vs Hydroquinone
NCT04875715
Use of CGM in Kidney Transplant Recipients
NCT04783441
Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial
NCT04652908
Dementia and Diabetes Prevention Program
NCT04141878
Effects of PFC tDCS on Cognitive Control, Attention Lapses and Coordinated Neural Activity in the Theta and Alpha Bands
NCT04885322
First-in-human Study of the Theranostic Pair [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G in Pancreatic Cancer
NCT04665947
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
NCT04314752
Imaging of Neuro-Inflammation and the Risk for Post-Traumatic Epilepsy
NCT03999164
Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
NCT04267003
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
NCT04166877
Heart Failure Precision Medicine Study
NCT04196842
TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
NCT03737604
Shaping Tolerance for Delayed Rewards
NCT03457402
Genetic Basis of Melanocytic Nevi
NCT03054584
Virtual Reality Attention Management
NCT03221244
Utilization of Negative Pressure Suction to Reduce Aspiration in Oropharyngeal Dysphagia
NCT03368079
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
NCT02232191
Factors Affect Outcomes in Cardiovascular Surgery
NCT01932411
Alternation in the Human Microbiome With Commonly Used Topical Medications
NCT03437005
Metabolic Responses to Bariatric Surgery
NCT02024542
Register for Pediatric Patients With Antiphospholipid Syndrome (APS): European Project Extended Internationally Study
NCT00616317
Studying Tumor Tissue Samples and Blood Samples to Learn More About DNA Changes in Patients With Lung Cancer
NCT00899405
CRAVE Study: Comparing Craving Responses and Diet Quality of GLP1 Receptor Agonist Users
NCT06467604
Nutrient and Hormonal Profile and Muscle Protein Synthesis Response to Consuming Chicken
NCT06489886
Effects of a Black Rice Extract and Anthocyanidin Metabolites on the Synthesis and Release of BDNF in Healthy Subjects
NCT06594848
Macronutrients in Lactating NICU Parents - Impact of Kangaroo Care
NCT06047470
Pilot Study: A Telehealth Intervention for Caregivers of Infants With Early Signs of ADHD
NCT05903053
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy
NCT05763199
EXPLORER Total Body PET/CT Imaging for Myofascial Pain
NCT05876858
ENDOblock: Bilateral Superficial Cervical Blocks With Local Wound Infiltration in Thyroid Surgery
NCT05805423
A Study of Positive Emotions With Long COVID-19
NCT05676008
Sickle Cell Disease (SCD) Bone Pain Study
NCT05283148
Newborn Abdominal Massage to Prevent Hyperbilirubinemia
NCT05282394
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
NCT05421689
Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption
NCT05321277
Neonatal Pulse Oximetry Disparities Due to Skin Pigmentation
NCT06063148
DASH Diet in Heart Failure Outpatients
NCT05117086
Olive Oil Polyphenols and Cardiovascular Health Biomarkers
NCT04149288
Evaluating the Impact of Telehealth-Based ASD Assessments and Supports on Child and Caregiver Outcomes
NCT04881656
Tumescence in HNC Skin Graft Reconstruction
NCT04967391
Hypotension Prediction Index: Correlations Between Invasive and Non-invasive Pressure Points.
NCT05025176
Brain Boosters 2 in Persons at Risk for Alzheimer's Disease: a Digital Application Supported Intervention
NCT05027789
Preductal Oxygen Saturation Target in Term and Late Preterm Neonates With Hypoxemic Respiratory Failure or Pulmonary Hypertension
NCT04938167
Influence of Sun Protection and Linear Repair of Cutaneous Surgical Defects
NCT05074238
Improving Health Awareness Using Social Network Interventions
NCT04850287
Multimodal Analgesia Effect on Post Surgical Patient
NCT04240626
Comparison of Imaging Characteristics of uEXPLORER and Conventional PET/CT in Patients With Lung Cancer, Lymphoma, and Melanoma
NCT04478318
Evaluation of Health Education Theater
NCT03759015
High-dose Vitamin D Supplements in Older Adults
NCT03613116
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, Davis pipeline card: 657 registered trials from official public datasets.Report a data error.